TMC - 89A和B，链霉菌属TC 1087产生的新型蛋白酶体抑制剂。 - Suppr

Suppr

超能文献

TMC-89A and B, new proteasome inhibitors from streptomyces sp. TC 1087.

作者信息

Koguchi Y, Nishio M, Suzuki S, Takahashi K, Ohnuki T, Komatsubara S

机构信息

Department of Basic Technology, Tanabe Seiyaku Co., Ltd., Saitama, Japan.

出版信息

J Antibiot (Tokyo). 2000 Sep;53(9):967-72. doi: 10.7164/antibiotics.53.967.

DOI:10.7164/antibiotics.53.967

PMID:11099231

Abstract

摘要

相似文献

TMC-89A and B, new proteasome inhibitors from streptomyces sp. TC 1087.TMC - 89A和B，链霉菌属TC 1087产生的新型蛋白酶体抑制剂。

J Antibiot (Tokyo). 2000 Sep;53(9):967-72. doi: 10.7164/antibiotics.53.967.

Entry into a new class of potent proteasome inhibitors having high antiproliferative activity by structure-based design.通过基于结构的设计进入一类具有高抗增殖活性的新型强效蛋白酶体抑制剂。

J Med Chem. 2004 Sep 23;47(20):4810-3. doi: 10.1021/jm049660v.

AJI9561, a new cytotoxic benzoxazole derivative produced by Streptomyces sp.AJI9561，一种由链霉菌属产生的新型细胞毒性苯并恶唑衍生物。

J Antibiot (Tokyo). 2001 Jan;54(1):102-4. doi: 10.7164/antibiotics.54.102.

TMC-86A, B and TMC-96, new proteasome inhibitors from Streptomyces sp. TC 1084 and Saccharothrix sp. TC 1094. I. Taxonomy, fermentation, isolation, and biological activities.TMC - 86A、B和TMC - 96，链霉菌属TC 1084和糖丝菌属TC 1094产生的新型蛋白酶体抑制剂。I. 分类学、发酵、分离及生物活性

J Antibiot (Tokyo). 1999 Dec;52(12):1069-76. doi: 10.7164/antibiotics.52.1069.

Isolation and structural determination of phepropeptins A, B, C, and D, new proteasome inhibitors, produced by Streptomyces sp.链霉菌属产生的新型蛋白酶体抑制剂A、B、C和D型苯丙肽菌素的分离与结构测定

J Antibiot (Tokyo). 2001 Nov;54(11):874-81. doi: 10.7164/antibiotics.54.874.

A new structural class of selective and non-covalent inhibitors of the chymotrypsin-like activity of the 20S proteasome.一类新型的20S蛋白酶体胰凝乳蛋白酶样活性的选择性非共价抑制剂的结构类别。

Bioorg Med Chem Lett. 2001 May 21;11(10):1317-9. doi: 10.1016/s0960-894x(01)00205-0.

Recent advances in the identification and development of 20S proteasome inhibitors.

Mini Rev Med Chem. 2002 Jun;2(3):247-59. doi: 10.2174/1389557023406142.

Modeling of the binding mode of a non-covalent inhibitor of the 20S proteasome. Application to structure-based analogue design.

Bioorg Med Chem Lett. 2001 May 21;11(10):1321-4. doi: 10.1016/s0960-894x(01)00206-2.

Pestaloquinols A and B, isoprenylated epoxyquinols from Pestalotiopsis sp.杀虫醌醇 A 和 B，来自 Pestalotiopsis sp 的异戊烯基环氧倍半萜

J Nat Prod. 2011 Feb 25;74(2):286-91. doi: 10.1021/np100723t. Epub 2011 Feb 8.

Tyropeptins A and B, new proteasome inhibitors produced by Kitasatospora sp. MK993-dF2. I. Taxonomy, isolation, physico-chemical properties and biological activities.酪肽素A和B，由北里孢菌属MK993 - dF2产生的新型蛋白酶体抑制剂。I. 分类学、分离、理化性质及生物活性

J Antibiot (Tokyo). 2001 Dec;54(12):997-1003. doi: 10.7164/antibiotics.54.997.

引用本文的文献

Chemoenzymatic Synthesis of Novel Cytotoxic Epoxyketones Using the Eponemycin Biosynthetic Enzyme EpnF.利用依波霉素生物合成酶 EpnF 的全酶化学酶促合成新型细胞毒性环氧化酮。

ACS Chem Biol. 2023 Jun 16;18(6):1360-1367. doi: 10.1021/acschembio.3c00080. Epub 2023 May 12.

Natural product scaffolds as inspiration for the design and synthesis of 20S human proteasome inhibitors.天然产物骨架作为设计和合成20S人蛋白酶体抑制剂的灵感来源。

RSC Chem Biol. 2020 Dec 1;1(5):305-332. doi: 10.1039/d0cb00111b. Epub 2020 Sep 16.

Genetic basis for the biosynthesis of the pharmaceutically important class of epoxyketone proteasome inhibitors.环氧酮蛋白酶体抑制剂类药物的生物合成的遗传基础。

ACS Chem Biol. 2014 Jan 17;9(1):301-9. doi: 10.1021/cb400699p. Epub 2013 Nov 8.

Proteasome regulators: activators and inhibitors.蛋白酶体调节剂：激活剂和抑制剂

Curr Med Chem. 2009;16(8):931-9. doi: 10.2174/092986709787581860.

Development and characterization of proteasome inhibitors.蛋白酶体抑制剂的研发与特性分析

Methods Enzymol. 2005;399:585-609. doi: 10.1016/S0076-6879(05)99039-3.

The ubiquitin-proteasome pathway and proteasome inhibitors.泛素-蛋白酶体途径与蛋白酶体抑制剂

Med Res Rev. 2001 Jul;21(4):245-73. doi: 10.1002/med.1009.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验